A judge has struck down New Hampshire’s Medicaid work requirements program, which requires certain beneficiaries to report work or work-related activities in order to keep their health insurance coverage, in a decision that stemmed from a lawsuit against HHS.

The U.S. National Institute on Aging (NIA) has awarded a five-year $47 million grant to the University of California, Berkeley to incorporate imaging into an ongoing study investigating whether lifestyle changes can help protect against dementia.

Chris Semsarian, PhD, MPH, has been announced as the newest editor-in-chief of the American Heart Association’s journal Circulation: Genomic and Precision Medicine.

Plastic surgeons can apply “emotional AI” algorithms to social media as a way of predicting which specific services will bring in business, according to a study running in the August edition of Plastic and Reconstructive Surgery.

Pfizer, one of the nation’s largest pharmaceutical companies, is merging its off-patent and generic drug business with Mylan, a global generic and specialty pharmaceutical company based in the Netherlands. The spinoff deal is expected to close mid-2020, pending shareholder and regulatory approvals.

President Trump is reportedly working on another executive order targeting rising drug prices, according to Reuters. 

The Australian Nuclear Science and Technology Organization (ANSTO) is raising its prices, according to a new report from The Australian.

Maquet and Datascope issued a nationwide recall of 22,853 intra-aortic balloon pumps July 23 following reports of five patient deaths and numerous battery failures.